Lyngby, Denmark

Mads Aage Laustsen

This inventor holds 7 USPTO granted patents. Top assignees: Novo Nordisk A/s, Novozymes A/s. Active years: 1998-2003.


% Patents Active = 100.0

Average Co-Inventor Count = 2.5

ph-index = 3

Forward Citations = 46(Granted Patents)


Company Filing History:


Years Active: 1998-2003

Loading Chart...
7 patents (USPTO):Explore Patents

Title: Mads Aage Laustsen: Innovator in Microfiltration Technologies

Introduction

Mads Aage Laustsen is a notable inventor based in Lyngby, Denmark. He has made significant contributions to the field of microfiltration, holding a total of 7 patents. His work focuses on innovative processes that enhance the efficiency of filtration methods, particularly in fermentation-derived products.

Latest Patents

Among his latest patents is a method for microfiltration using activated carbon. This process involves adding activated carbon to a solution of a fermentation-derived product prior to or during the microfiltration process, operating at temperatures ranging from 25°C to 65°C. Another significant patent relates to the recovery of glycosidase or peptidase from a culture broth at high pH. This invention outlines a method for transitioning these enzymes from an unsolubilized state to a solubilized state within the culture solution.

Career Highlights

Mads has worked with prominent companies such as Novo Nordisk A/S and Novozymes A/S. His experience in these organizations has allowed him to develop and refine his innovative ideas in the field of biotechnology and filtration technologies.

Collaborations

Throughout his career, Mads has collaborated with talented individuals, including Birgitte Mahler Nilsson and Anders Rancke-Madsen. These partnerships have contributed to the advancement of his research and the successful implementation of his inventions.

Conclusion

Mads Aage Laustsen is a distinguished inventor whose work in microfiltration technologies has led to several important patents. His innovative approaches continue to influence the field and demonstrate the potential for advancements in biotechnology.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…